|
Market Cap (2-Jul) $51,232,372 (781st) |
Close (30-Jun) $0.250 |
Volume (30-Jun) 84,565 |
Shortsold (19-Jun) 845,024 (0.14%) (403rd) |
|
52w High $0.59 |
52w Low $0.075 |
P/E 8.00 |
EPS -0.01 |
MDR released this announcement to the ASX on 28 October 2022, 10:58. The announcement is not marked as price sensitive, and is 40 page(s) in length and 607.97kb in size.
You can view all announcements from MDR and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDR was 0.017% short sold according to ASIC data. It was ranked the 606th most shorted stock on the ASX. It is now ranked as the 403rd most shorted stock on the ASX with 0.135% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from MDR | |
|---|---|
| MDR undertakes strategic review | 22 June 2023, 9:51 |
| Initial Director's Interest Notice - Kate Hill | 29 May 2023, 11:05 |
| Initial Director's Interest Notice - Brett Magun | 29 May 2023, 11:00 |
| Notice of Annual General Meeting | 28 October 2022, 10:58 |
| Quarterly Report and Appendix 4C | 27 October 2022, 14:04 |
| MedAdvisor September Quarterly (1Q FY23) Briefing | 25 October 2022, 8:59 |
| MDR appoints US health tech exec Kevin Hutchinson to Board | 19 October 2022, 14:28 |
You must be logged in to post a reply.
MedAdvisor 